Search results
FDA advisory panel recommends new Alzheimer's drug after scrutiny
United Press International via Yahoo News· 2 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 1 day agoCurrently, Swiss sunscreen company DSM-Firmenich is working to secure FDA approval for bemotrizinol....
FERC OK's Mountain Valley Pipeline: A Brief on the Project
Zacks via Yahoo Finance· 1 day agoEnvironmental groups continue to highlight the potential risks associated with the pipeline....
Chase Sapphire Preferred review: A standout travel card with impressive perks
Yahoo Personal Finance· 1 day agoAnnual fee: While there are many rewards cards without annual fees, this card has a $95 annual fee....
Market research firm predicts major price changes to EV industry in coming years: 'Entering a new...
The Cool Down via Yahoo News· 1 day agoIn certain situations, it may then become more cost-effective to write off vehicles than to fix...
Today's Refinance Rates: June 13, 2024—Rates Dip
Forbes· 13 hours agoThe rate on a 30-year fixed refinance tumbled today. The average rate on a 30-year fixed mortgage refinance is 7.48%, according to Curinos, while the...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 13 hours agoLilly and Biogen carry a Zacks Rank #3 (Hold...Amazingly, they soared with average gains of +44.9%,...
The plan to end the middle-class child benefit tax farce
The Telegraph via Yahoo Finance· 7 days agoThe charge has been... means households with two parents both earning up to £60,000 can keep any...
US health advisers back drug to slow Alzheimer's disease
Euronews via Yahoo News· 2 days agoBut most panellists thought there was enough evidence of the drug's benefit to prescribe it broadly,...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
WIS News 10 Columbia· 3 days agoFood and Drug Administration advisers voted unanimously that the drug’s ability to modestly slow the...